Expression of the human antiviral DNA cytosine deaminase APOBEC3B in mice accelerates tumor development and promotes tumor heterogeneity including overt phenotypic differences, thousands of signature single base substitution mutations (SBS2), and larger-scale chromosomal aberrations including insertion-deletion mutations and structural variations. This evidence concerns the gene APOBEC3B and neoplasm.